Samsara BioCapital, L.P.

13F Holdings History for Mineralys Therapeutics, Inc. - Common Stock (MLYS)

Symbol: MLYS on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 6.35M shares
Security Ownership: 8.2%

Srinivas Akkaraju ownership in Mineralys Therapeutics, Inc. Common Stock (MLYS)

2025-09-08 - Srinivas Akkaraju has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.35M shares of Mineralys Therapeutics, Inc. Common Stock (MLYS). This represents 8.2% percent ownership of the company. In their previous filing dated 2025-03-17, Samsara BioCapital, L.P. had reported owning 5.74M shares, indicating an increase of 10.6% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Srinivas Akkaraju	8.2%	-10%	$96.6M	6.35M	+609,889	+10.6%	$15.22	13D/A	9/4/2025	8 Sep 2025 20:05:45
Srinivas Akkaraju	9.1%		$73.6M	5.74M			$12.83	13D/A	3/13/2025	17 Mar 2025 21:06:42